Ventora Medical has been awarded $50k in funding through LaunchVic’s Medtech Market Growth Program.
The Medtech Market Growth Program (MMGP) is designed to help Victorian medtech startups accelerate their path to market. When announcing the grant recipients, the Minister for Medical Research Ben Carroll said “This program is supporting startups and scaleups to get their innovative life-saving products to the hospitals and healthcare providers caring for Victorians.”
The MMGP will support Ventora to expand its internal engineering and quality capabilities and will help fund further product refinement and market research.
Ventora’s Chief Executive Officer, Edward Buijs, said: “The MMGP grant is further validation of the work Ventora Medical is doing to help premature babies breathe."
"We are grateful for the recognition and support of LaunchVic and the Department of Jobs, Skills, Industry and Regions through the MedTech Market Growth Program Grant."
See LaunchVic's announcement here.
Improving Neonatal Respiratory Care
Respiratory distress is one of the leading causes of morbidity and mortality in newborns, particularly in premature infants with underdeveloped lungs. Current non-invasive breathing support systems are often the first-line treatment for respiratory distress, as they avoid the risks associated with intubation and mechanical ventilation. However, there are several limitations associated with these systems. Their non-invasive nature means that they are susceptible to leaks, leading to uncertain pressure delivery to the infant's airway and high failure rates.
To address this need, Ventora Medical is developing an airway pressure monitor for neonatal patients on non-invasive respiratory support. The device will provide accurate and continuous monitoring of the mean airway pressure without adding invasiveness to treatment and with minimal procedural change. The device aims to provide objective feedback of the delivered pressure to enable clinicians to provide proactive and tailored respiratory treatment. By improving the delivery of non-invasive respiratory support, Ventora’s device aims to reduce failure rates, decrease length of time on respiratory support and improve patient outcomes.
Advancing Our Mission
At Ventora Medical, we are committed to empowering clinicians through innovation and helping premature babies breathe through the development and commercialisation of our first product, the Ventora Airway Pressure Monitor. With the support of LaunchVic through the MMGP program, we are excited to continue our journey towards delivering an innovative solution that impacts the lives of vulnerable infants and their families.
Stay tuned for more updates!
About the Medtech Market Growth Program (MMGP)
The Medtech Market Growth Progam (MMGP) is delivered through a collaboration between LaunchVic and the Department of Jobs, Skills, Industry and Regions. The MMGP aims to support Victorian scaling medtech startups accelerate their pathway to market.
Comentarios